Almas M - Search Results

1

Prediction of therapeutic response to pregabalin in subjects with neuropathic pain.

Almas M, Parsons B, Whalen E. Almas M, et al. Curr Med Res Opin. 2018 Dec;34(12):2041-2052. doi: 10.1080/03007995.2018.1520694. Epub 2018 Oct 18. Curr Med Res Opin. 2018. PMID: 30183410

2

Does Duration of Neuropathic Pain Impact the Effectiveness of Pregabalin?

Pérez C, Latymer M, Almas M, Ortiz M, Clair A, Parsons B, Varvara R. Pérez C, et al. Among authors: almas m. Pain Pract. 2017 Apr;17(4):470-479. doi: 10.1111/papr.12469. Epub 2016 Sep 2. Pain Pract. 2017. PMID: 27589095

3

Effect of Concomitant Pain Medications on Response to Pregabalin in Patients with Postherpetic Neuralgia or Spinal Cord Injury-Related Neuropathic Pain.

Schug SA, Parsons B, Almas M, Whalen E. Schug SA, et al. Among authors: almas m. Pain Physician. 2017 Jan-Feb;20(1):E53-E63. Pain Physician. 2017. PMID: 28072797 Free article. Clinical Trial.

4

Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials.

Serpell M, Latymer M, Almas M, Ortiz M, Parsons B, Prieto R. Serpell M, et al. Among authors: almas m. J Pain Res. 2017 Jul 26;10:1769-1776. doi: 10.2147/JPR.S129832. eCollection 2017. J Pain Res. 2017. PMID: 28794656 Free PMC article.

5

Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis.

Montgomery SA, Lyndon G, Almas M, Whalen E, Prieto R. Montgomery SA, et al. Among authors: almas m. Int Clin Psychopharmacol. 2017 Jan;32(1):41-48. doi: 10.1097/YIC.0000000000000144. Int Clin Psychopharmacol. 2017. PMID: 27583543

6

Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database.

Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Almas M, Parsons B. Diener HC, et al. Among authors: almas m. Cephalalgia. 2008 Jan;28(1):35-40. doi: 10.1111/j.1468-2982.2007.01457.x. Epub 2007 Oct 16. Cephalalgia. 2008. PMID: 17941878

7

Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.

Martin VT, Valade D, Almas M, Hettiarachchi J, Sikes C, Albert KS, Parsons B. Martin VT, et al. Among authors: almas m. Headache. 2007 Feb;47(2):181-8. doi: 10.1111/j.1526-4610.2006.00685.x. Headache. 2007. PMID: 17300357 Clinical Trial.

8

Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.

Dodick DW, Lipton RB, Goadsby PJ, Tfelt-Hansen P, Ferrari MD, Diener HC, Almas M, Albert KS, Parsons B. Dodick DW, et al. Among authors: almas m. Headache. 2008 Feb;48(2):184-93. doi: 10.1111/j.1526-4610.2007.00868.x. Headache. 2008. PMID: 18234045

9

Treatment-emergent CNS symptoms following triptan therapy are part of the attack.

Goadsby PJ, Dodick DW, Almas M, Diener HC, Tfelt-Hansen P, Lipton RB, Parsons B. Goadsby PJ, et al. Among authors: almas m. Cephalalgia. 2007 Mar;27(3):254-62. doi: 10.1111/j.1468-2982.2007.01278.x. Cephalalgia. 2007. PMID: 17381558 Review.

10

Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.

Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Winner P, et al. Among authors: almas m. Headache. 2007 Apr;47(4):511-8. doi: 10.1111/j.1526-4610.2007.00755.x. Headache. 2007. PMID: 17445100 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters